LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.